The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Subgroup analysis by fitness criteria of patients (pts) with blastic plasmacytoid dendritic cell neoplasm (BPDCN) treated with first-line (1L) tagraxofusp (TAG).
 
Naveen Pemmaraju
Employment - MD Anderson Cancer Center
Leadership - ASCO; ASH
Consulting or Advisory Role - Abbvie; Aplastic Anemia and MDS International Foundation; Aptitude Health; Astellas Pharma; Blueprint Medicines; Bristol Myers Squibb; CancerNet; CareDx; Celgene; Cimeio Therapeutics; Clearview Healthcare Partners; CTI BioPharma Corp; Curio Science; Dava Oncology; EUSA Pharma; Harborside Press; Imedex; Immunogen; Intellisphere; Intellisphere; Magdalen Medical Publishing; Medscape; Menarini Group; Neopharm; Novartis; OncLive; Pacylex; Patient Power; Peerview; Pharmaessentia; Physicans' Education Resource
Research Funding - US DOD (Inst)
Other Relationship - Karger Publishers
(OPTIONAL) Uncompensated Relationships - Dan's House of Hope; Oncology Times
 
Marco Herling
Honoraria - BeiGene; Janssen; Menarini Group; Stemline Therapeutics; Takeda
Consulting or Advisory Role - BeiGene; Janssen; Menarini Group; Stemline Therapeutics; Takeda
Research Funding - BeiGene (Inst); Janpix (Inst)
Expert Testimony - Menarini Group; Stemline Therapeutics
Travel, Accommodations, Expenses - BeiGene; Janssen
 
Kendra Sweet
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Jazz Pharmaceuticals; Nkarta; Novartis
Research Funding - Incyte; Jazz Pharmaceuticals
Expert Testimony - Nelson Mullins
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Jazz Pharmaceuticals
Other Relationship - Karyopharm Therapeutics
 
Anthony Stein
Honoraria - Amgen; Debiopharm Group; Syndex Bio
Consulting or Advisory Role - Debiopharm Group; Sanofi and Daiichi Sankyo; Syndex Bio
Speakers' Bureau - Amgen
 
Sumithira Vasu
Research Funding - Sanofi (Inst)
Other Relationship - Alexion Pharmaceuticals
 
Todd Rosenblat
Honoraria - Astellas Pharma
Research Funding - Astex Pharmaceuticals; Celator
 
David Rizzieri
Other Relationship - Cellectis
 
Cristina Papayannidis
Honoraria - Abbvie; Amgen; Astellas Pharma; Bristol-Myers Squibb; Incyte; Janssen; Menarini Group; Novartis; Pfizer; SERVIER; Stemline Therapeutics
Consulting or Advisory Role - Abbvie; Astellas Pharma; Blueprint Pharmaceutic; Delbert Laboratories; GlaxoSmithKline; Imcheck Therapeutics; Istituto Gentili; Janssen; Jazz Pharmaceuticals; Pfizer
Other Relationship - Abbvie; Astellas Pharma; Blueprint Pharmaceutic; Delbert Laboratories; GlaxoSmithKline; Imcheck Therapeutics; Istituto Gentili; Janssen; Jazz Pharmaceuticals; Pfizer
 
Eunice Wang
Consulting or Advisory Role - Abbvie; Blueprint Medicines; Celgene/Bristol-Myers Squibb; CTI BioPharma Corp; Daiichi Sankyo/UCB Japan; GlaxoSmithKline; Immunogen; Johnson & Johnson/Janssen; Kite/Gilead; Kura Oncology; Novartis; Qiagen; Rigel; Ryvu Therapeutics; Schrodinger; SERVIER; Stemline Therapeutics; Sumitomo Pharma Oncology; Syndax; Takeda
Speakers' Bureau - Astellas Pharma; Daiichi Sankyo/UCB Japan; DAVA Pharmaceuticals; Pfizer
Other Relationship - Abbvie/Genentech; Gilead Sciences; Gilead Sciences; UpToDate
 
Marina Konopleva
Leadership - Immune Oncology
Consulting or Advisory Role - Abbvie; AstraZeneca; Boehringer Ingelheim; F. Hoffmann LaRoche; Genentech; Gilead Sciences; Janssen; Legend Biotech; MEI Pharma; Redona Therapeutics; Sanofi Aventis GmbH; Sellas Life Sciences; Stemline Therapeutics; Vincerx Pharma
Research Funding - Abbvie (Inst); Allogene Therapeutics (Inst); AstraZeneca; Cellectis; Genentech; Gilead Sciences; ImmunoGen; Janssen; MEI Pharma; Pfizer; Precision BioSciences; Rafael Pharmaceuticals; Sanofi Aventis GmbH; Stemline Therapeutics
Patents, Royalties, Other Intellectual Property - Reata Pharmaceuticals
Other Relationship - Abbvie; Auxenion GmbH; BAKX Therapeutics; Dark Blue Therapeutics; F. Hoffmann LaRoche; Genentech; Gilead Sciences; Stemline Therapeutics; Vincerx Pharma
 
Michael Zuurman
Employment - Menarini Group
 
Alessandra Tosolini
Employment - GlaxoSmithKline; Menarini Group
Stock and Other Ownership Interests - GlaxoSmithKline
Patents, Royalties, Other Intellectual Property - GlaxoSmithKline
 
Muzaffar Qazilbash
Research Funding - Angiocrine Bioscience (Inst); Janssen (Inst); Sanofi (Inst)
Other Relationship - Autolus
 
Andrew Lane
Stock and Other Ownership Interests - MedZown; Stelexis Therapeutics
Research Funding - Abbvie (Inst); Stemline Therapeutics (Inst)
Other Relationship - Cimeio Therapeutics; IDRx; Jnana Therapeutics; ProteinQure; Qiagen; Stelexis Therapeutics; Stemline Therapeutics